drugset / Trial / NCT00216242

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

NCT00216242

Phase 3 Unknown 7400 enrolled ID Biomedical Corporation, Quebec
RandomizedParallel-groupDouble-blindEct

Summary

The goal of this study is to determine whether Fluviral, an inactivated, injectable trivalent influenza vaccine (flu shot) is effective in preventing respiratory illnesses that are severe enough to limit normal daily activities and that are shown by virus culture to be caused by influenza viruses. The study will also examine the safety of the vaccine and collect measurements of the immune system responses produced by the vaccine.

Timeline

Start
2005-09
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluviral Vaccine

Indications